← Back to Search

Enteral Formula

Tube Feeding Formula Tolerance in Children

N/A
Recruiting
Led By Jessie Hulst, MD
Research Sponsored by Société des Produits Nestlé (SPN)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial tests a formula to check if it is safe and effective for kids.

Who is the study for?
This trial is for medically stable children aged 1 to 13 who are currently tube-fed and rely on it for at least 90% of their nutrition. They must be tolerating their current enteral feeding well and be deemed appropriate candidates for the study formula. Parents or guardians need to give signed consent.Check my eligibility
What is being tested?
The trial is testing a special formulated liquid diet designed for children who receive nutrition through tube feeding. The goal is to evaluate how effective, tolerable, and safe this new pediatric enteral formula is.See study design
What are the potential side effects?
Potential side effects may include digestive issues such as nausea, vomiting, diarrhea or constipation due to the new formula. Allergic reactions could also occur if the child has sensitivities to ingredients in the formula.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Nutritional efficacy - energy
Secondary outcome measures
Adverse events
Bristol Stool Chart
Frequency of nausea
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Enteral tube fed childrenExperimental Treatment1 Intervention
Children being fed an enteral formula with a feeding tube

Find a Location

Who is running the clinical trial?

Société des Produits Nestlé (SPN)Lead Sponsor
337 Previous Clinical Trials
62,535 Total Patients Enrolled
2 Trials studying Tube Feeding
50 Patients Enrolled for Tube Feeding
Krys Araujo Torres, MDStudy DirectorNestle Health Science USA
Jessie Hulst, MDPrincipal InvestigatorThe Hospital for Sick Children

Media Library

Pediatric Enteral Formula (Enteral Formula) Clinical Trial Eligibility Overview. Trial Name: NCT05838495 — N/A
Tube Feeding Research Study Groups: Enteral tube fed children
Tube Feeding Clinical Trial 2023: Pediatric Enteral Formula Highlights & Side Effects. Trial Name: NCT05838495 — N/A
Pediatric Enteral Formula (Enteral Formula) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838495 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it feasible for me to participate in this research trial?

"Applicants that are between 1 year old and 13 years of age, who have been prescribed tube feeding, can join this clinical trial. There is a total participant limit of 30 individuals."

Answered by AI

Is the enrollment age limit for this research study set at twenty or above?

"According to the parameters of this experiment, patients between 1 year and 13 years old are eligible. Moreover, 4 distinct studies have been created for minors while 5 were designed specifically for seniors aged 65 or more."

Answered by AI

Are there any available slots for participation in this research project?

"According to clinicaltrials.gov, this specific trial is not actively enrolling new patients at the moment. It was first posted on May 1st 2023 and last updated April 28th 2023. However, 8 other medical trials are open and recruiting candidates in the area right now."

Answered by AI
~2 spots leftby Jun 2024